Winston Resources Inc.

0.07

Canada & Ontario Toronto

4168 Finch Avenue East, Suite 308

+1 416 628-9879

www.winstonresourcesinc.com

Looking to explore investment opportunities with WRW?

Contact WRW >

Looking to explore investment opportunities with WRW?

Contact WRW >

Is this your business?
Customize your listing.

CLAIM THIS LISTING

Is this your business?
Customize your listing.

Company Press Releases

Winston Resources Provides Update Regarding Distribution of Common Shares of Abattis Bioceuticals to Shareholders

/THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/ VANCOUVER, June 1, 2018 /CNW/ - Winston Resources Inc. ("Winston" or the "Company") (CSE: WRW) (FSE:WNT) is pleased to announce that further to its news release on May 24, 2018, the Company intends to complete the distribution (the "Distribution") of a total of 15,000,000 common shares (the "Abattis Shares") of Abattis Bioceuticals Corp. ("Abattis") on or about June 8, 2018 on a pro rata basis to the Company's shareholders of re...

Winston Resources Announces Distribution of Common Shares of Abattis Bioceuticals to Winston Resources Shareholders

/THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/ VANCOUVER, May 24, 2018 /CNW/ - Winston Resources Inc. ("Winston" or the "Company") (CSE: WRW; FSE:WNT) is pleased to announce that further to its news release on January 11, 2018 that the Company intends to distribute the 15,000,000 common shares (the "Abattis Shares") of Abattis Bioceuticals Corp. ( "Abattis") on a pro rata basis to the holders of record as of January 23, 2018 (the "Winston Shareholders") of common shares of Winsto...

Winston Resources Assigns Share Exchange Agreement with Green Tree Therapeutics

/THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/ VANCOUVER, Jan. 12, 2018 /CNW/ - Winston Resources Inc. ("Winston" or the "Company") (CSE: WRW; FSE:WNT) is pleased to announce that it has entered into an assignment and novation agreement dated effective January 10, 2018 (the "Assignment Agreement") among the Company, GT Therapeutics Corporation, dba Green Tree Therapeutics ("GTT"), certain shareholders of GTT and Abattis Bioceuticals Corp. ("Abattis"). Pursuant to the terms...

See All >

Company News

See All >

NEWSLETTER